Compare Recursion Pharmaceuticals Inc (RXRX) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Utilities Select Sector SPDR Fund — how do they compare? Recursion Pharmaceuticals Inc trades at $4.36 (market cap $2.14B), while Utilities Select Sector SPDR Fund trades at $41.39 (market cap $23.60B). The key difference: Utilities Select Sector SPDR Fund is far larger — about 11× Recursion Pharmaceuticals Inc's market cap, and Recursion Pharmaceuticals Inc is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Recursion Pharmaceuticals Inc for 23 Days and Utilities Select Sector SPDR Fund for 80 Days on average.
| RXRX | XLU | |
|---|---|---|
Market Cap | $2.14B | $23.60B |
Volume | 30,789,535 | 28,758,237 |
Sector | Health | — |
52-Week High | $6.79 | $47.73 |
52-Week Low | $2.84 | $39.25 |
Typical Hold Time | 23 Days | 80 Days |
Enterprise Value | $1.66B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Recursion Pharmaceuticals (RXRX) trades at $3.95, down 7.49% today, with a mixed technical picture showing bullish moving averages but neutral oscillators. The company reported Q2 2026 earnings miss after two consecutive beats, while maintaining negative profitability metrics with a -961.97% net income margin. Recent strategic partnerships with Tempus and Roche aim to expand the AI-driven drug discovery pipeline through 2028.
RXRX presents high-risk growth potential with strong analyst support (40% buy rating) but faces substantial financial challenges including persistent losses and negative cash flow from operations. The stock's investment case hinges on successful pipeline development and partnership monetization, though current valuation appears stretched at 37.14x sales given the lack of profitability.
XLU trades at $41.07, down 0.19% on the day, as utility stocks face pressure from rising interest rates. The ETF recently hit 52-week lows amid sector-wide selling, though technical indicators show a mixed picture with bullish moving averages but neutral oscillators. Recent news highlights oversold conditions in utilities, with the sector experiencing its steepest monthly drop in nearly two years according to 24/7 Wall Street (2026-10-02).
The outlook remains challenged by interest rate sensitivity, but defensive characteristics could provide support if economic uncertainty persists. Key risks include continued rate hikes and regulatory headwinds, while potential catalysts include defensive rotation during market volatility and AI-driven power demand growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
